Biomaterials specialized company


We have the solution you need



- Registered 12 new DMF products and filed 11 new drug approvals
- Reached USD 81.2 million in sales
- Launching of Ashland's Pharmaceutical Excipients product

<2023 Patent Registration
Patent No. : No. 10-2501636
Invention Name: Manufacturing method and oral tablet including phenoflibrinic acid
Patentee: Ace Biopharm and Yonsei University Industry-Academic Cooperation Center


- Approved DMF registration for a total of 187 APIs
(Approved DMF registration for 25 APIs in 2022)
- Relocation of head office B/D(Bangbae-dong)
- 2022 Turn over : 100.3 billion won


Approval on DMF registration of 162 products
Generate over 86.3 milion dollar of sales
Changed company name : Ace Biopharm Co., Ltd.
Certification as Family-friendly company
Certification as an excellent employment stability company
ISO and FSSC 22000 Certification at Pyeongtaek plant
Certification of Global Small-Giants Company


Designated as a Hi Seoul Brand Company
Designated as a Youth-friendly small giant
Designated as a Promising Export Firm


M&A Acebiotech
Established a BIO Research Center in Daejeon
Generated 71 billion won of sales
Won the grand prize for 2019 Korea win-win development


Registered DMF 79 items
Generated 58 billion won of sales
Established a Research Institute
Certified as a KGIP laboratory
Registered 3 patents related to Vitamin K2 production and applied for 1 patent


Registered DMF 60 items
Generated 55 billion won of sales
Extended Logistics Center
Designated as a small giant and excellent technology competency


Moved into Dongjin Pharma owned building
Generated 50 billion won of sales


Registered DMF 40 items
Certified a member of MAINBIZ (MAINBIZ is the certification for managerial innovative company in Korea)
Generated 30 billion won of sales


Generated 20 billion won of sales


Established an affiliate company, Ace Biotech


Generated 11 billion won of sales
Signed exclusive supply contracts with over 20 companies with over 20 items


Established Dongjin Pharma

[06784] 41, Dongsan-ro 8-gil, Seocho-gu, Seoul, Republic of Korea
CEO : Min-Byoung Gyu /  TEL : +82-2-579-1056  /  FAX : +82-2-6008-3356  /  E-mail :

Copyright © 2010 ABP company. All Rights Reserved.